NeuroXess
Huangpu
About NeuroXess
NeuroXess provides brain-computer interface (BCI) products and solutions for scientific research, including neural signal acquisition systems and specialized electrodes. Their offerings support applications such as epilepsy diagnosis, ALS treatment, stroke rehabilitation, and other neurological conditions. They also develop neural signal recording and analysis software and offer tailored lab and discipline construction plans in neuroscience. Support services include consultations, documentation, and 1-on-1 after-sales assistance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $15.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: neuroxess.com
- Phone: 400 080 6565
Industries & Categories
Health Care, Health Diagnostics, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neuroxess-93431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.